In this webinar, we will dive into the intricacies of implementing electronic informed consent (eConsent) in clinical trials within the complex regulatory landscape of European countries.
About this webinar
Recent industry statistics demonstrate that the adoption of eConsent has been gaining popularity, with a 33 percent increase in usage from 2019 to 2020 across Europe. Nevertheless, one of the foremost challenges is ensuring compliance with local regulations and ethical guidelines while maintaining secure, accurate, informative and accessible eConsent processes for all participants.
To overcome these hurdles, clinical trials sponsors may need to validate their eConsent processes and systems, provide comprehensive training to study staff and participants, work closely with regulatory authorities and collaborate with technology vendors to develop eConsent solutions tailored to their specific needs.
It is important to note that the adoption of eConsent has the potential to enhance the informed consent process, but it is vital to carefully consider regulatory requirements and ethical guidelines.
- Learn how to navigate local and ethical guidelines when implementing eConsent in Europe
- Discover the importance of developing a robust change management programme to earn stakeholder acceptance and adoption of new technologies
- Explore the top three considerations when choosing an eConsent technology partner.